LCTX Projected Dividend Yield
Lineage Cell Therapeutics Inc ( AMEX : LCTX )Lineage Cell Therapeutics is a clinical-stage biotechnology company focused on developing allogeneic cell therapies for unmet medical needs. Utilizing its cell-based technology platform, Co. designs, develops, manufactures, and tests specialized human cells with specific anatomical and physiological functions. Its neuroscience pipeline includes OpRegen, a retinal pigment epithelial cell therapy in Phase IIa for geographic atrophy due to age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy in Phase I/IIa for spinal cord injuries; and ANP1, an auditory neuronal progenitor cell therapy for auditory neuropathy. 21 YEAR PERFORMANCE RESULTS |
LCTX Dividend History Detail LCTX Dividend News LCTX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |